GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » Enlitic Inc (ASX:ENL) » Definitions » Return-on-Tangible-Equity

Enlitic (ASX:ENL) Return-on-Tangible-Equity : 0.00% (As of . 20)


View and export this data going back to 2023. Start your Free Trial

What is Enlitic Return-on-Tangible-Equity?

Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Enlitic's annualized net income for the quarter that ended in . 20 was A$ Mil. Enlitic's average shareholder tangible equity for the quarter that ended in . 20 was A$ Mil. Therefore, Enlitic's annualized Return-on-Tangible-Equity for the quarter that ended in . 20 was %.

The historical rank and industry rank for Enlitic's Return-on-Tangible-Equity or its related term are showing as below:

ASX:ENL's Return-on-Tangible-Equity is not ranked *
in the Healthcare Providers & Services industry.
Industry Median: 10.32
* Ranked among companies with meaningful Return-on-Tangible-Equity only.

Enlitic Return-on-Tangible-Equity Historical Data

The historical data trend for Enlitic's Return-on-Tangible-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Enlitic Return-on-Tangible-Equity Chart

Enlitic Annual Data
Trend Dec23
Return-on-Tangible-Equity
-142.24

Enlitic Quarterly Data
Dec23
Return-on-Tangible-Equity -

Competitive Comparison of Enlitic's Return-on-Tangible-Equity

For the Health Information Services subindustry, Enlitic's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Enlitic's Return-on-Tangible-Equity Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Enlitic's Return-on-Tangible-Equity distribution charts can be found below:

* The bar in red indicates where Enlitic's Return-on-Tangible-Equity falls into.



Enlitic Return-on-Tangible-Equity Calculation

Enlitic's annualized Return-on-Tangible-Equity for the fiscal year that ended in Dec. 2023 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(A: Dec. 2023 )  (A: . 20 )(A: Dec. 2023 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets )/ count )
(A: Dec. 2023 )  (A: . 20 )(A: Dec. 2023 )
=/( (+ )/ )
=/
= %

Enlitic's annualized Return-on-Tangible-Equity for the quarter that ended in . 20 is calculated as

Return-on-Tangible-Equity=Net Income/( (Total Tangible Equity+Total Tangible Equity)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=Net Income/( (Total Stockholders Equity - Intangible Assets+Total Stockholders Equity - Intangible Assets)/ count )
(Q: . 20 )  (Q: . 20 )(Q: . 20 )
=/( (+)/ )
=/
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data, the net income data used here is four times the quarterly (. 20) net income data. Return-on-Tangible-Equity is displayed in the 10-year financial page.


Enlitic  (ASX:ENL) Return-on-Tangible-Equity Explanation

Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.


Be Aware

Net Income is used.

Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.

Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.


Enlitic Return-on-Tangible-Equity Related Terms

Thank you for viewing the detailed overview of Enlitic's Return-on-Tangible-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Enlitic (ASX:ENL) Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
3420 East Harmony Road, Suite 125, Fort Collins, CO, USA, 80528
Enlitic Inc is focused on artificial intelligence that enables effective administration, processing, and sharing of medical imaging data throughout the healthcare enterprise. It is also focused on developing tools that solve longstanding challenges in radiology rather than developing point solutions that exacerbate the issues radiology faces. Enlitic provides a solid plan that addresses data inconsistencies and risk associated with moving studies containing PHI and is focused on using AI for the medical imaging layer of a real-world evidence (RWE), providing healthcare organizations with a stepwise approach to operationalizing their AI.

Enlitic (ASX:ENL) Headlines

No Headlines